Letara 2.5mg (10 Tablet / Pack)
Prescription oral aromatase inhibitor tablet for breast cancer therapy and ovulation induction.
Letara 2.5mg Tablets are an oral prescription non-steroidal aromatase inhibitor indicated for the treatment of hormone-dependent breast cancer in postmenopausal women. By selectively blocking the aromatase enzyme, it blocks the peripheral synthesis of estrogen in body tissues, effectively depriving hormone-receptor-positive cancer cells of their primary growth stimulus. It is also utilized in specialized reproductive protocols to stimulate ovulation in women facing infertility.
Purpose
Used to lower systemic estrogen production to treat postmenopausal breast cancer and manage infertility.
Ingredients
Letrozole 2.5mg
Warnings
Contraindicated for use during active pregnancy due to severe risks of fetal harm. Regularly monitor bone mineral density during long-term therapy due to elevated osteoporosis risks. May cause significant dizziness and fatigue; avoid driving or operating heavy machinery. Confirm postmenopausal status through laboratory testing prior to initializing oncological therapy.
Side Effects
Hot flashes or excessive sweating Joint pain or muscle stiffness Fatigue or general weakness Mild nausea or thinning hair
Storage Instructions
Store below 25°C in its original blister pack away from moisture.
| Status | Active |